LARNEFPENDEKIN ALFA

UNII:	CAJ4WR863D
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	LARNEFPENDEKIN ALFA
GSRS Full Record:	CAJ4WR863D i

2877653-03-5
Human interleukin-15 (IL-15) (1-114, 2-115 in the current sequence, D1>added, variant (N72>D73) fused via peptide linker 116AGGKPGGSAGG126 to gamma 1 heavy chain (127-454) [Homo sapiens IGHG1*08 (CH1 (127-224), hinge (225-239), CH2 L243>A, L244>A (240-349), CH3 (350-454), CHS G455>del, K456>del)], (229-216')-disulfide with kappa light chain (110'-216') [Homo sapiens IGKC*01] fused via peptide linker 104'GAEGGG109' to human interleukin-15 receptor subunit alpha (IL-15R-alpha, IL-15RA, CD215) (1'-103', variant I1'>D), dimer (235-235'':238-238'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-S, glycoform alfa
Human interleukin-15 (IL-15) fused via a peptide linker to human immunoglobulin G1 constant heavy chain, disulfide-bridged to human immunoglobulin kappa constant light chain fused via a peptide linker to human interleukin-15 receptor subunit alpha (IL-15R-alpha, IL-15RA, CD215)
Larnefpendekin Alfa
larnefpendekin alfa [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LARNEFPENDEKIN ALFA

Synonyms and Mappings

Resources